By David Weiss
The COVID-19 pandemic sparked the reimagining of the pharmaceutical industry, illustrating the possibilities — and benefits — of fully remote commerce. Among other things, we’ve learned that bringing drugs to market needn’t be a 10-year slog and that pharma can be smarter, faster, and more efficient.
David Weiss outline three lessons for the pharmaceutical industry to carry forward post-COVID:
This byline originally appeared in STAT.
Complexity demands a trusted guide with the unique expertise and cross-sector versatility to deliver unwavering success. We work with organizations across regulated commercial and public sectors to catalyze transformation and pioneer new directions for the future.